# The Medicines for Human Use (Clinical Trials) (Amendment) (EU Exit) Regulations 2019, Regulation 17: Amendment of regulation 36 (requirement for authorisation to manufacture or import investigational medicinal products)

Extent: E+W+S+N.I.

In regulation 36(2), after “marketing authorization” insert “or marketing authorisation issued by the competent authority of an EEA State in accordance with Directive 2001/83/EC”.

---
Source: https://www.legislation.gov.uk/uksi/2019/744/regulation/17 (the official version)
Page: https://openlegislation.uk/medicines-for-human-use-clinical-trials-amendment-eu-exit-regulations-2019/regulation-17
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.